Exploring the efficacy of E ۹۴۴۷ Anti-cancer Agent binding to PARP۱: a molecular dynamics simulation approach

سال انتشار: 1403
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 154

فایل این مقاله در 15 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

BCSCD03_015

تاریخ نمایه سازی: 27 اسفند 1403

چکیده مقاله:

Poly polymerase ۱, a protein of the PARP family, is involved in the cellular processes of DNA damage repair and apoptosis. Disabilities within the work of this protein can lead to distinctive illnesses, including cancer. E۹۴۴۷ is a novel PARP inhibitor with great potential as a cancer therapeutic. The point of this study is to investigate the interaction between E ۹۴۴۷ and the PARP ۱ protein. In this study, a model of PARP۱ protein was created with Modeller ۷۱۱۶ software. First, we chose a model of PARP ۱ with a high degree of similarity to the Protein Data Bank, and introduction of this model into the simulation stage was based on energy. Simulation of its molecular dynamics was performed via GROMACS, after which its connection areas with E ۹۴۴۷ were ascertained by AutoDock ۴۱۴ software. The stability of the root mean square deviation diagram and energy indicated that the three-dimensional structural model was stable and closely approximated natural PARP ۱. Docking studies also showed that this protein has an attachment site

نویسندگان

Hamed Esmaeil Lashgarian

Associate Professor, Department of Medical Biotechnology, Faculty of Medicine, Lorestan University

Vahideh Assadollahi

Assistant Professor, Department of Tissue Engineering & Applied Cell Sciences, School of Advanced Technologies, Shahrekord University of Medical Sciences, Shahrekord, Iran.

Masumeh Jalalvand

Assistant Professor, Department of Medical Biotechnology, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.

Hamidreza Khodadadi

Assistant Professor, Hepatitis Research Center, Department of Medical Biotechnology, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran

Leila Abkhooie

Assistant Professor, Department of Medical Biotechnology, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.

Amirmasoud Jalalvand

Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.